Cargando…

Nuclear Osteopontin Is a Marker of Advanced Heart Failure and Cardiac Allograft Vasculopathy: Evidence From Transplant and Retransplant Hearts

BACKGROUND: Heart transplant is the gold standard therapy for patients with advanced heart failure. Over 5,500 heart transplants are performed every year worldwide. Cardiac allograft vasculopathy (CAV) is a common complication post-heart transplant which reduces survival and often necessitates heart...

Descripción completa

Detalles Bibliográficos
Autores principales:	Irion, Camila Iansen, Dunkley, Julian C., John-Williams, Krista, Condor Capcha, José Manuel, Shehadeh, Serene A., Pinto, Andre, Loebe, Matthias, Webster, Keith A., Brozzi, Nicolas A., Shehadeh, Lina A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Physiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7438570/ https://www.ncbi.nlm.nih.gov/pubmed/32903540 http://dx.doi.org/10.3389/fphys.2020.00928

Ejemplares similares

Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia
por: Irion, Camila Iansen, et al.
Publicado: (2018)

Mouse Model of Heart Failure With Preserved Ejection Fraction Driven by Hyperlipidemia and Enhanced Cardiac Low‐Density Lipoprotein Receptor Expression
por: Williams, Monique, et al.
Publicado: (2022)

Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery
por: Hersh, Jessica, et al.
Publicado: (2021)

Heart Retransplant Recipients Have Better Survival With Concurrent Kidney Transplant Than With Heart Retransplant Alone
por: Savla, Jill, et al.
Publicado: (2015)

S2 Heart Sound Detects Aortic Valve Calcification Independent of Hemodynamic Changes in Mice
por: Dargam, Valentina, et al.
Publicado: (2022)

Osteopontin and LDLR Are Upregulated in Hearts of Sudden Cardiac Death Victims With Heart Failure With Preserved Ejection Fraction and Diabetes Mellitus
por: Patel, Mausam, et al.
Publicado: (2020)

Cardiac allograft vasculopathy in Dutch heart transplant recipients
por: Galli, G., et al.
Publicado: (2016)

Col4a3(-/-) Mice on Balb/C Background Have Less Severe Cardiorespiratory Phenotype and SGLT2 Over-Expression Compared to 129x1/SvJ and C57Bl/6 Backgrounds
por: Irion, Camila I., et al.
Publicado: (2022)

Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
por: Chuang, Sung-Ting, et al.
Publicado: (2022)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Ascending aortic aneurysm and histopathology in Alport syndrome: a case report
por: Kamiar, Ali, et al.
Publicado: (2023)

A preclinical model for phenogroup 3 HFpEF
por: Yousefi, Keyvan, et al.
Publicado: (2019)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
por: Condor Capcha, Jose Manuel, et al.
Publicado: (2021)

Do LDE-Methotrexate lipid nanoparticles decrease allograft vasculopathy in rabbit transplanted heart ?
por: Stolf, N, et al.
Publicado: (2013)

Early Inflammatory Markers Are Independent Predictors of Cardiac Allograft Vasculopathy in Heart-Transplant Recipients
por: Labarrere, Carlos A., et al.
Publicado: (2014)

Accelerated Cardiac Allograft Vasculopathy in an Orthotopic Heart Transplant Recipient with Prior COVID-19
por: Parikh, Neil U., et al.
Publicado: (2023)

Interleukin 21 (IL-21) regulates chronic allograft vasculopathy (CAV) in murine heart allograft rejection
por: Khattar, Mithun, et al.
Publicado: (2019)

Autoimmune Reaction Associated With Long COVID Syndrome and Cardiovascular Disease: A Genetic Case Report
por: Safronenka, Anita, et al.
Publicado: (2022)

Immunogenicity of retransplanted rat kidney allografts. Effect of inducing chimerism in the first recipient and quantitative studies on immunosuppression of the second recipient
Publicado: (1982)

Development and Validation of a Comprehensive Model to Estimate Early Allograft Failure Among Patients Requiring Early Liver Retransplant
por: Avolio, Alfonso W., et al.
Publicado: (2020)

Cardiac allograft vasculopathy and donor age affecting permanent pacemaker implantation after heart transplantation
por: Roest, Stefan, et al.
Publicado: (2022)

Case report: Heart retransplant from a donor after circulatory death and extended transport period with normothermic perfusion
por: Kasinpila, Patpilai, et al.
Publicado: (2023)

Diagnosis of chronic allograft vasculopathy using semiquantitative stress perfusion CMR in heart transplant patients
por: Schwid, Madeline, et al.
Publicado: (2016)

Coronary Collateral Circulation: A New Predictor of Mortality in Heart Transplant Recipients With Allograft Vasculopathy
por: Civieri, Giovanni, et al.
Publicado: (2023)

Clinical implementation of coronary computed tomography angiography for routine detection of cardiac allograft vasculopathy in heart transplant patients
por: Nous, Fay M. A., et al.
Publicado: (2021)

Deletion of Osteopontin Enhances β(2)-Adrenergic Receptor-Dependent Anti-Fibrotic Signaling in Cardiomyocytes
por: Pollard, Celina M., et al.
Publicado: (2019)

Diagnosis of cardiac allograft vasculopathy in heart transplant patients using a pixelated stress perfusion analysis
por: Hanna, Alexander Benjamin
Publicado: (2019)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Diagnostic Accuracy of Dobutamine Stress Echocardiography for Detection of Cardiac Allograft Vasculopathy in Orthotopic Heart Transplant Patients
por: Mahmoodurrahman, Mohammed, et al.
Publicado: (2021)

Low-Density Lipoprotein Cholesterol Level Trends and the Development of Cardiac Allograft Vasculopathy After Heart Transplantation
por: Aleksova, Natasha, et al.
Publicado: (2021)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Methotrexate associated to lipid core nanoparticles improves cardiac allograft vasculopathy and the inflammatory profile in a rabbit heart graft model
por: Fiorelli, A.I., et al.
Publicado: (2017)

The novel proteomic signature for cardiac allograft vasculopathy
por: Wei, Dongmei, et al.
Publicado: (2022)

Super-response to cardiac resynchronization therapy in orthotopic heart transplant with atypical right bundle branch block and cardiac allograft vasculopathy
por: Ballout, Jad A., et al.
Publicado: (2022)

Cytomegalovirus infection and disease reduce 10-year cardiac allograft vasculopathy-free survival in heart transplant recipients
por: Johansson, Inger, et al.
Publicado: (2015)

Stratification of Arrhythmic Risk Using Remote Patient Monitoring in a Heart Transplant Recipient with Coronary Allograft Vasculopathy
por: Žorž, N., et al.
Publicado: (2021)

Low MicroRNA-126 Levels in Right Ventricular Endomyocardial Biopsies Coincide With Cardiac Allograft Vasculopathy in Heart Transplant Patients
por: Heggermont, Ward A., et al.
Publicado: (2020)

Effect of Statin Intensity on the Progression of Cardiac Allograft Vasculopathy
por: Ellimuttil, Tracey M, et al.
Publicado: (2021)

Age-related molecular genetic changes of murine bone marrow mesenchymal stem cells
por: Wilson, Amber, et al.
Publicado: (2010)

Early Cardiac Allograft Vasculopathy: Are the Viruses to Blame?
por: Aggarwal, Ashim, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_eu82h3cmgnb7mr4tjdg51nfrs9